Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: GC Genome Corporation

Market Cap 115B 75.09M 65.47M 60.63M 56.76M 106M 7.08B 107M 719M 279M 3.49B 282M 276M 12.11B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 55.54M 36.28K 31.64K 29.3K 27.43K 51.44K 3.42M 51.75K 348K 135K 1.69M 136K 133K 5.85M EV / Sales 2026 *
1.42x
EV / Sales 2027 * 0.95x
Free-Float
49.59%
Yield 2026 *
-
Yield 2027 * -
1 day+0.21%
1 week-8.82%
Current month-19.27%
1 month-28.21%
3 months-38.48%
6 months-30.77%
Current year-28.74%
1 week 4,660
Extreme 4660
5,710
1 month 4,660
Extreme 4660
7,190
Current year 4,660
Extreme 4660
9,520
1 year 4,660
Extreme 4660
10,250
3 years 4,660
Extreme 4660
15,180
5 years 4,660
Extreme 4660
15,180
10 years 4,660
Extreme 4660
15,180
Manager TitleAgeSince
Chief Executive Officer 57 26/03/2020
Director of Finance/CFO 50 27/03/2025
Comptroller/Controller/Auditor 45 29/03/2024
Director TitleAgeSince
Director/Board Member 57 30/03/2023
Date Insider Type Main position Quantity % Market Cap.
17/06/25Free

Chief Executive Officer

169,285 -
17/06/25Free 138,250 -
Change 5-day change 1-year change 3-year change Capi.($)
+0.21%-8.82%-52.02% - 74.93M
-3.71%+2.17%+30.12%+318.03% 33.14B
-0.43%-4.25%-2.78%+8.03% 20.98B
-1.20%-1.93%-24.93%-44.26% 6.95B
+1.86%-4.37%-0.57%+66.53% 4.23B
+2.20%+4.39%+14.81%+49.81% 2.9B
-4.53%-8.34%-29.49%+822.92% 1.75B
+0.12%-2.61%-8.65%-66.59% 1.68B
+7.62%-0.81%+44.44%-24.96% 1.65B
-2.17%-0.67%+12.22%-5.22% 1.58B
Average +0.01%-1.25%-1.69%+124.92% 7.49B
Weighted average by Cap. -1.61%+1.00%+11.07%+161.75%

Financials

2026 *2027 *
Net sales 39B 25.48M 22.21M 20.57M 19.26M 36.12M 2.4B 36.34M 244M 94.59M 1.18B 95.63M 93.58M 4.11B 48.8B 31.88M 27.79M 25.74M 24.1M 45.19M 3.01B 45.47M 305M 118M 1.48B 120M 117M 5.14B
Net income - -
Net Debt -59.4B -38.8M -33.83M -31.33M -29.33M -55.01M -3.66B -55.34M -372M -144M -1.8B -146M -143M -6.26B -68.8B -44.94M -39.19M -36.29M -33.97M -63.72M -4.24B -64.1M -431M -167M -2.09B -169M -165M -7.25B
Logo GC Genome Corporation
GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.
Employees
-
Date Price Change Volume
22/06/26 4,860.00 +0.21% 193,941
19/06/26 4,850.00 -6.91% 156,603
18/06/26 5,210.00 -4.05% 188,178
17/06/26 5,430.00 +4.22% 374,911
16/06/26 5,210.00 -2.07% 84,395

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A340450 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!